Подписаться
Richard Keefe
Richard Keefe
Professor of Psychiatry and Behavioral Sciences
Подтвержден адрес электронной почты в домене duke.edu
Название
Процитировано
Процитировано
Год
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman, TS Stroup, JP McEvoy, MS Swartz, RA Rosenheck, ...
New England journal of medicine 353 (12), 1209-1223, 2005
73922005
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity
KH Nuechterlein, MF Green, RS Kern, LE Baade, DM Barch, JD Cohen, ...
American Journal of Psychiatry 165 (2), 203-213, 2008
23872008
Persistent cannabis users show neuropsychological decline from childhood to midlife
MH Meier, A Caspi, A Ambler, HL Harrington, R Houts, RSE Keefe, ...
Proceedings of the National Academy of Sciences 109 (40), E2657-E2664, 2012
19312012
The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery
RSE Keefe, TE Goldberg, PD Harvey, JM Gold, MP Poe, L Coughenour
Schizophrenia research 68 (2-3), 283-297, 2004
16222004
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial
RSE Keefe, RM Bilder, SM Davis, PD Harvey, BW Palmer, JM Gold, ...
Archives of general psychiatry 64 (6), 633-647, 2007
13972007
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment
JP McEvoy, JA Lieberman, TS Stroup, SM Davis, HY Meltzer, ...
American Journal of Psychiatry 163 (4), 600-610, 2006
12242006
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria
MF Green, KH Nuechterlein, JM Gold, DM Barch, J Cohen, S Essock, ...
Biological psychiatry 56 (5), 301-307, 2004
11332004
The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis
RSE Keefe, SG Silva, DO Perkins, JA Lieberman
Schizophrenia bulletin 25 (2), 201-222, 1999
10211999
Antipsychotic drug effects on brain morphology in first-episode psychosis
JA Lieberman, GD Tollefson, C Charles, R Zipursky, T Sharma, RS Kahn, ...
Archives of general psychiatry 62 (4), 361-370, 2005
9382005
Schizophrenia is a cognitive illness: time for a change in focus
RS Kahn, RSE Keefe
JAMA psychiatry 70 (10), 1107-1112, 2013
9032013
Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment
PD Harvey, RSE Keefe
American journal of psychiatry 158 (2), 176-184, 2001
8842001
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization
RS Kern, KH Nuechterlein, MF Green, LE Baade, WS Fenton, JM Gold, ...
American Journal of Psychiatry 165 (2), 214-220, 2008
7942008
Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study
A Reichenberg, A Caspi, HL Harrington, R Houts, RSE Keefe, RM Murray, ...
American Journal of Psychiatry 167 (2), 160-169, 2010
6602010
Barriers to employment for people with schizophrenia
R Rosenheck, D Leslie, R Keefe, J McEvoy, M Swartz, D Perkins, ...
American Journal of Psychiatry 163 (3), 411-417, 2006
6592006
Cognitive impairment in schizophrenia
RSE Keefe, PD Harvey
Novel antischizophrenia treatments, 11-37, 2012
6202012
Baseline neurocognitive deficits in the CATIE schizophrenia trial
RSE Keefe, RM Bilder, PD Harvey, SM Davis, BW Palmer, JM Gold, ...
Neuropsychopharmacology 31 (9), 2033-2046, 2006
5872006
How Should DSM-V Criteria for Schizophrenia Include Cognitive Impairment?
RSE Keefe, WS Fenton
Schizophrenia bulletin 33 (4), 912-920, 2007
5802007
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic
TS Stroup, JA Lieberman, JP McEvoy, MS Swartz, SM Davis, ...
American Journal of Psychiatry 163 (4), 611-622, 2006
5772006
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia
RW Buchanan, M Davis, D Goff, MF Green, RSE Keefe, AC Leon, ...
Schizophrenia bulletin 31 (1), 5-19, 2005
5672005
A genome-wide investigation of SNPs and CNVs in schizophrenia
AC Need, D Ge, ME Weale, J Maia, S Feng, EL Heinzen, KV Shianna, ...
PLoS genetics 5 (2), e1000373, 2009
5582009
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20